Isabel Luzeiro

ORCID: 0000-0002-8610-194X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Migraine and Headache Studies
  • Trigeminal Neuralgia and Treatments
  • Long-Term Effects of COVID-19
  • Cardiovascular and Diving-Related Complications
  • Ophthalmology and Eye Disorders
  • Sympathectomy and Hyperhidrosis Treatments
  • Vestibular and auditory disorders
  • Sleep and related disorders
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Pain Mechanisms and Treatments
  • Restless Legs Syndrome Research
  • Epilepsy research and treatment
  • Congenital Heart Disease Studies
  • Mobile Health and mHealth Applications
  • Obstructive Sleep Apnea Research
  • Peripheral Neuropathies and Disorders
  • Neurological and metabolic disorders
  • Youth, Drugs, and Violence
  • Retinal and Optic Conditions
  • Cardiovascular Syncope and Autonomic Disorders
  • Mosquito-borne diseases and control
  • Health, Nursing, Elderly Care
  • Cerebrovascular and Carotid Artery Diseases
  • Cerebrovascular and genetic disorders
  • Neurological disorders and treatments

Hospitais da Universidade de Coimbra
2008-2024

Escola Superior de Tecnologia da Saúde de Coimbra
2020-2024

University of Coimbra
2016-2024

Hospital Braga
2022

Polytechnic Institute of Coimbra
2022

University of Lisbon
2016

Background Anti-CGRP monoclonal antibodies (anti-CGRP MAbs) are approved and available treatments for migraine prevention. Patients do not respond alike many countries have reimbursement policies, which hinder to those who might respond. This study aimed investigate clinical factors associated with good excellent response anti-CGRP MAbs at 6 months. Methods European multicentre, prospective, real-world study, including high-frequency episodic or chronic (CM) patients treated since March 2018...

10.1136/jnnp-2023-333295 article EN Journal of Neurology Neurosurgery & Psychiatry 2024-05-22

Objective: The aim of this study was to evaluate sleep and awakening quality (SQ AQ) during COVID-19 in a large diversified population order identify significant associations risks terms demography, health health-related behaviors, variables, mental health, attitudes. Methods/Results:Online surveys were used for data collection, received from 5479 individuals the general population, disorder patients, COVID-involved (medical doctors (MDs) nurses) COVID-affected professionals (teachers,...

10.3390/ijerph18073506 article EN International Journal of Environmental Research and Public Health 2021-03-28

As cefaleias são uma causa significativa de incapacidade a nível global, com enxaqueca ocupar o segundo lugar entre as doenças mais anos vividos incapacidade. A maioria dos doentes cefaleias, incluindo enxaqueca, podem e devem ser diagnosticados, tratados acompanhados eficazmente nos cuidados saúde primários. Isso não só reduz associada estas patologias, mas também previne progressão para formas crónicas ou uso excessivo medicamentos. criação rede eficiente referenciação, envolvendo...

10.20344/amp.22496 article PT cc-by-nc-nd Acta Médica Portuguesa 2025-05-02

Abstract Background Migraine Disability Assessment Scale (MIDAS) is a useful tool to measure headache-related disability. Modified MIDAS with 4-week recall period reduces bias and improves accuracy of the results. This study aimed at validating mMIDAS in Portuguese. Methods Studied population consisted adult migraine patients attending headache outpatient clinic. Reliability was assessed by internal consistency reproducibility 3-week test-retest. Content validity evaluated two expert panels....

10.1186/s12883-021-02085-z article EN cc-by BMC Neurology 2021-02-06

Background: Chronic medical disorders (CMD) are highly prevalent and often associated with multiple mental physical comorbidities, which amplify health risks pose significant challenges for long-term treatment, contributing to their substantial burden on individuals healthcare systems. During the pandemic CMD were particularly affected. Portugal besides having a higher prevalence of is among countries used more strict protective measures subsequent negative impacts. Objectives: The paper...

10.33425/2993-6799.1018 article EN Japanese Journal of Medical Research 2024-12-31

Background: Medical professionals nowadays must be well-versed in the most recent, scientifically confirmed facts on illness diagnosis, treatment, and patient care. Despite fact that there are an increasing number variety of information sources available to physicians, many questions remain concerning authenticity, quality, usefulness medical information. With goal improving current delivery, new methodologies needed assess doctors’ real-life demands. Objective: The this study was explore...

10.51249/hs.v4i01.1908 article EN cc-by Health and Society 2024-02-25

Providência, A.; Silva, C. S.; Costa, M. P.; Quintal, N. Luzeiro, I. M.; Leitao-Marques, A. Author Information

10.1097/00003643-200801001-00094 article EN European Journal of Anaesthesiology 2008-01-01

Providência, A.; Silva, C. S.; Costa, M. P.; Quintal, N. Luzeiro, I. M; Leitao-Marques, A. Author Information

10.1097/00003643-200801001-00093 article EN European Journal of Anaesthesiology 2008-01-01

Abstract Background Migraine Disability Assessment Scale (MIDAS) is a useful tool to measure headache-related disability. Modified MIDAS with 4-week recall period reduces bias and improves accuracy of the results. This study aimed at validating mMIDAS in Portuguese. Methods Studied population consisted adult migraine patients attending headache outpatient clinic. Reliability was assessed by internal consistency reproducibility 3-week test-retest. Content validity evaluated two expert panels....

10.21203/rs.3.rs-66829/v1 preprint EN cc-by Research Square (Research Square) 2020-10-29

Introduction: The onabotulinumtoxinA (onabotA) is an injectable preventive treatment of chronic migraine (CM), administered in 12 week’s intervals. Some patients present a wearing-off (WO) effect the last weeks before next treatment. aim our study was to evaluate WO phenomen under onabotA and recognize possible predictive features phenomena. Methods: We designed cross-sectional proceeded demographic clinical characterization group patients, evaluation therapeutic response adverse events....

10.46531/sinapse/ao/220079/2023 article EN Sinapse 2023-05-19

Introduction: REM sleep behavior disorder (RBD) is diagnosed by clinical history of abnormal and complex movements during polysomnographic findings. Accordingly, RBD may occur isolated (iRBD) or, frequently, in association with neurodegenerative diseases, namely synucleinopathies generally preceding its onset. Thereby, our aim was to characterize the video-polysomnography (vPSG) features patients iRBD plus Parkinson disease (RBDPD); analyze symptoms signs (motor non-motor) that RBDPD...

10.46531/sinapse/ao/210084/2022 article EN Sinapse 2022-08-05

Migraine is one of the most prevalent chronic diseases. The COVID-19 pandemic and consequent deep remodeling health care may have contributed to worsening migraine. We aim study impact on patients with Cross-sectional migraine followed in a Neurology outpatient clinic. Patients completed an online survey that included variables related migraine, treatment healthcare approachability. A total 97 survey, mostly female (92.8%), mean age 43.3 years old, full-time job (60.8%), 14.4% changed...

10.1016/j.jns.2021.119338 article EN other-oa Journal of the Neurological Sciences 2021-10-01

10.1016/s0013-4694(97)88994-1 article EN Electroencephalography and Clinical Neurophysiology 1997-07-01
Coming Soon ...